Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RiBVD in Elderly Mantle Cell Lymphoma
NCT00740415Phase 2Completed
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Jun 2007
- Primary completion
- May 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in mantle cell lymphoma (MCL), sponsored by French Innovative Leukemia Organisation. Started Jun 2007; status: completed.
02
Drugs
bortezomib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00740415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740415.